Innoviva (INVA) Current Assets (2010 - 2026)
Innoviva posted quarterly Current Assets of $772.6 million for Q1 2026, up 32.75% year-on-year from $582.0 million in Q1 2025, and up 6.2% on a QoQ basis from $727.5 million in Q4 2025.
Innoviva (INVA) has 17 years of Current Assets data on file, last reported at $772.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 32.75% year-over-year to $772.6 million; the trailing twelve-month figure through Mar 2026 stood at $772.6 million (up 32.75% YoY), and the FY2025 full-year result was $727.5 million, up 31.25% from the prior year.
- Current Assets for Q1 2026 stood at $772.6 million, up from $727.5 million in the prior quarter.
- Across five years, Current Assets topped out at $772.6 million in Q1 2026 and bottomed at $16.9 million in Q3 2025.
- The 5-year median for Current Assets is $344.2 million (2023), against an average of $364.3 million.
- The widest annual swing landed in 2022, when Current Assets soared 170.02%; it then slumped 38.8% in 2024.
- A 5-year view of Current Assets shows it stood at $443.5 million in 2022, then decreased by 22.39% to $344.2 million in 2023, then jumped by 61.03% to $554.3 million in 2024, then soared by 31.25% to $727.5 million in 2025, then gained by 6.2% to $772.6 million in 2026.
- The last three Current Assets figures came in at $772.6 million (Q1 2026), $727.5 million (Q4 2025), and $16.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 772.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 772.62 Mn |
| Dec 31, 2025 | 727.52 Mn |
| Sep 30, 2025 | 16.93 Mn |
| Jun 30, 2025 | 651.78 Mn |
| Mar 31, 2025 | 582.02 Mn |
| Dec 31, 2024 | 554.31 Mn |
| Sep 30, 2024 | 22.39 Mn |
| Jun 30, 2024 | 358.28 Mn |
| Mar 31, 2024 | 311.34 Mn |
| Dec 31, 2023 | 344.22 Mn |
| Sep 30, 2023 | 36.59 Mn |
| Jun 30, 2023 | 323.54 Mn |
| Mar 31, 2023 | 296.45 Mn |
| Dec 31, 2022 | 443.51 Mn |
| Sep 30, 2022 | 33.25 Mn |
| Jun 30, 2022 | 400.33 Mn |
| Mar 31, 2022 | 317.82 Mn |
| Dec 31, 2021 | 313.67 Mn |
| Sep 30, 2021 | 49.75 Mn |
| Jun 30, 2021 | 148.26 Mn |
| Mar 31, 2021 | 372.93 Mn |
| Dec 31, 2020 | 342.06 Mn |
| Sep 30, 2020 | 68.40 Mn |
| Jun 30, 2020 | 500.19 Mn |
| Mar 31, 2020 | 466.91 Mn |
| Dec 31, 2019 | 431.23 Mn |
| Sep 30, 2019 | 366.80 Mn |
| Jun 30, 2019 | 317.69 Mn |
| Mar 31, 2019 | 251.52 Mn |
| Dec 31, 2018 | 199.04 Mn |
| Sep 30, 2018 | 121.13 Mn |
| Jun 30, 2018 | 178.66 Mn |
| Mar 31, 2018 | 113.25 Mn |
| Dec 31, 2017 | 200.37 Mn |
| Sep 30, 2017 | 220.51 Mn |
| Jun 30, 2017 | 198.06 Mn |
| Mar 31, 2017 | 214.42 Mn |
| Dec 31, 2016 | 198.05 Mn |
| Sep 30, 2016 | 186.12 Mn |
| Jun 30, 2016 | 190.42 Mn |
| Mar 31, 2016 | 196.71 Mn |
| Dec 31, 2015 | 214.33 Mn |
| Sep 30, 2015 | 223.75 Mn |
| Jun 30, 2015 | 243.96 Mn |
| Mar 31, 2015 | 262.39 Mn |
| Dec 31, 2014 | 252.18 Mn |
| Sep 30, 2014 | 273.47 Mn |
| Jun 30, 2014 | 353.16 Mn |
| Mar 31, 2014 | 389.20 Mn |
| Dec 31, 2013 | 483.20 Mn |
| Sep 30, 2013 | 522.34 Mn |
| Jun 30, 2013 | 457.23 Mn |
| Mar 31, 2013 | 474.51 Mn |
| Dec 31, 2012 | 261.13 Mn |
| Sep 30, 2012 | 282.54 Mn |
| Jun 30, 2012 | 303.38 Mn |
| Mar 31, 2012 | 204.33 Mn |
| Dec 31, 2011 | 244.76 Mn |
| Sep 30, 2011 | 269.17 Mn |
| Jun 30, 2011 | 288.63 Mn |
| Dec 31, 2010 | 316.35 Mn |